Arcutis Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Okay. Good afternoon, everyone. Welcome to the 2:10 PM session on day three of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover European and US biopharma for Goldman Sachs.
With me today for a fireside chat is Arcutis Biotherapeutics. I'm joined by Frank Watanabe. He's the CEO of the Company. John Smither, the Chief Financial Officer; and Ken Lock, who's the Chief Commercialization Officer. So gentlemen, thank you for joining us. Welcome to your first Goldman Sachs Healthcare Conference. I wish I were out in California with you, with better weather. But the virtual format is going swimmingly well, so I'm glad we're able to do this. So, welcome.
Our pleasure to be here. Look forward to seeing you guys out in Southern California before too long.
Great. Thanks so much. Arcutis is a relatively new company, especially as a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
